J. B. CHEMICALS & PHARMACEUTICALS LIMITED

J. B. Chemicals & Pharmaceuticals Limited

JBCHEPHARM

INE572A01036

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:00:54 15/07/2024 BST			5-day change	1st Jan Change
1,784 ^INR	+2.07%		+2.76%	+9.83%

07-09	J. B. Chemicals & Pharmaceuticals Limited Appoints Arun Duggal, Non-Executive Independent Director, as the Non-Executive Chairman	CI
07-05	J. B. Chemicals & Pharmaceuticals Limited Approves the Appointment of Arun Duggal as Non-Executive Independent Director	CI

J. B. Chemicals & Pharmaceuticals Limited Appoints Arun Duggal, Non-Executive Independent Director, as the Non-Executive Chairman

July 09, 2024 at 12:29 pm

The board of directors of J. B. Chemicals & Pharmaceuticals Limited at its meeting held on July 9, 2024, have appointed Mr. Arun Duggal (DIN: 00024262), Non-Executive Independent Director, as the Non-Executive Chairman of the Company.

Latest news about J. B. Chemicals & Pharmaceuticals Limited

J. B. Chemicals & Pharmaceuticals Limited Appoints Arun Duggal, Non-Executive Independent Director, as the Non-Executive Chairman	07-09	CI
J. B. Chemicals & Pharmaceuticals Limited Approves the Appointment of Arun Duggal as Non-Executive Independent Director	07-05	CI
Jefferies Adjusts JB Chemicals & Pharmaceuticals' Price Target to INR2,060 From INR2,000, Keeps at Buy	05-22	MT
Transcript : J. B. Chemicals & Pharmaceuticals Limited, Q4 2024 Earnings Call, May 21, 2024	05-21
J. B. Chemicals & Pharmaceuticals Seeks Acquisition Opportunities	05-19	CI
J. B. Chemicals & Pharmaceuticals Limited Recommends Final Dividend for the Year 2023-2024	05-17	CI
J. B. Chemicals & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-17	CI
J. B. Chemicals & Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-17	CI
KKR to buy India's Healthium Medtech at $839 million valuation, sources say	05-06	RE
J. B. Chemicals & Pharmaceuticals Limited Receives Order from Office of the Commissioner, GST and Central Excise, Vadodara	04-30	CI
J. B. Chemicals & Pharmaceuticals Limited Receives Order from Joint Commissioner State Tax, Lucknow II, Lucknow	04-26	CI
J. B. Chemicals & Pharmaceuticals Limited Appoints Akshay Tanna as A Non-Executive, Non-Independent Director	04-08	CI
J. B. Chemicals & Pharmaceuticals Limited Receives Order from Assessment Unit, Income Tax Department	03-22	CI
J. B. Chemicals & Pharmaceuticals Limited Announces Demise of Ranjit Shahani, Chairman and Non-Executive, Independent Director	03-09	CI
KKR Reportedly Considers Selling Controlling Stake in JB Pharma	02-28	CI
Jefferies Adjusts JB Chemicals & Pharmaceuticals' Price Target to INR2,000 From INR1,970, Keeps at Buy	02-08	MT
JB Chemicals' Consolidated Profit Climbs in Fiscal Q3; Shares Jump 4%	02-07	MT
J.B. Pharma Seeks Acquisitions	02-07	CI
Transcript : J. B. Chemicals & Pharmaceuticals Limited, Q3 2024 Earnings Call, Feb 07, 2024	02-07
J. B. Chemicals & Pharmaceuticals Appoints CFO	02-07	MT
JB Chemicals Names CFO	02-06	MT
Indian drugmaker J B Chemicals posts Q3 profit rise on strong demand	02-06	RE
J. B. Chemicals & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-06	CI
J. B. Chemicals & Pharmaceuticals Limited Appoints Narayan Saraf as the Chief Financial Officer, with Effect from February 23, 2024	02-06	CI
J. B. Chemicals & Pharmaceuticals Limited Declares Interim Dividend for Financial Year 2023-24	02-06	CI

Chart J. B. Chemicals & Pharmaceuticals Limited

Duration

Period

Chart J. B. Chemicals & Pharmaceuticals Limited

More charts

Company Profile

J. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its therapeutic categories include gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives and pharmacovigilance. The Company's lozenges products include center-filled, soft-centered lozenges; center-filled, powder lozenges; herbal lozenges, and medicated lozenges. The Company offers a complete range of contrast media products including X-ray, MRI, and ultrasound in India as well as internationally. The Company produces a wide range of dosage forms, such as tablets, capsules, liquids, IV infusions, ampoules, vials, ointments, cold rubs, lozenges and sips. Its brands include Rantac OD, RD, Ranraft, Metrogyl ER, Metrogyl O, Nicardia XL, Sporlac EVA and Sporlac G, among others.

Sector

Pharmaceuticals

Calendar

07/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for J. B. Chemicals & Pharmaceuticals Limited

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1,784 INR

Average target price

1,975 INR

Spread / Average Target

+10.72%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
J. B. CHEMICALS & PHARMACEUTICALS LIMITED	+9.83%	3.25B
ELI LILLY AND COMPANY	+63.05%	854B
NOVO NORDISK A/S	+39.42%	636B
JOHNSON & JOHNSON	-4.78%	361B
MERCK & CO., INC.	+17.52%	324B
ABBVIE INC.	+8.43%	301B
ASTRAZENECA PLC	+14.19%	247B
ROCHE HOLDING AG	+5.81%	230B
NOVARTIS AG	+16.77%	228B
AMGEN INC.	+14.63%	177B

Other Pharmaceuticals